Literature DB >> 6132834

In vitro degradation of the C-terminal octapeptide of cholecystokinin by 'enkephalinase A'.

M Deschodt-Lanckman, A D Strosberg.   

Abstract

As the C-terminal octapeptide of cholecystokinin represents a putative neurotransmitter in the central nervous system, the membrane-bound enzymes involved in its inactivation were investigated. Two aminopeptidases, involved in the cleavage of enkephalins, and a metalloendopeptidase were identified in extracts of solubilized synaptic membranes. The metalloendopeptidase, which cleaves CCK-8 at the Trp30-Met31 bond, appeared to be indistinguishable from 'enkephalinase A1' on the basis of its chromatographic behaviour, sensitivity to inhibitors and relative affinities for Met- and Leu-enkephalins. This finding indicates that CCK-8 is inactivated in vitro by the same peptidases as enkephalins.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6132834     DOI: 10.1016/0014-5793(83)80493-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Opposite central and peripheral control by endogenous opioids of intestinal motility in fed rats.

Authors:  P J Rivière; M Liberge; D Murillo-Lopez; L Bueno
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

Review 2.  Neprilysin inhibition: a new therapeutic option for type 2 diabetes?

Authors:  Nathalie Esser; Sakeneh Zraika
Journal:  Diabetologia       Date:  2019-05-14       Impact factor: 10.122

3.  Insulinotropic Effects of Neprilysin and/or Angiotensin Receptor Inhibition in Mice.

Authors:  Nathalie Esser; Christine Schmidt; Breanne M Barrow; Laura Cronic; Daryl J Hackney; Stephen M Mongovin; Meghan F Hogan; Andrew T Templin; Joseph J Castillo; Rebecca L Hull; Sakeneh Zraika
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-06       Impact factor: 6.055

4.  Purification of endopeptidase-24.11 ('enkephalinase') from pig brain by immunoadsorbent chromatography.

Authors:  J M Relton; N S Gee; R Matsas; A J Turner; A J Kenny
Journal:  Biochem J       Date:  1983-12-01       Impact factor: 3.857

5.  Cholecystokinin-octapeptide constricts guinea-pig and human airways.

Authors:  C D Stretton; P J Barnes
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

6.  Reduction of food intake by central administration of cholecystokinin octapeptide in the rat is dependent upon inhibition of brain peptidases.

Authors:  T Griesbacher; G E Leighton; R G Hill; J Hughes
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

Review 7.  Cholecystokinin and pain: a review.

Authors:  J W McRoberts
Journal:  Anesth Prog       Date:  1986 Mar-Apr

8.  Sacubitril/valsartan increases postprandial gastrin and cholecystokinin in plasma.

Authors:  Ulrik Ø Andersen; Dijana Terzic; Nicolai Jacob Wewer Albrechtsen; Peter Dall Mark; Peter Plomgaard; Jens F Rehfeld; Finn Gustafsson; Jens P Goetze
Journal:  Endocr Connect       Date:  2020-05       Impact factor: 3.335

9.  miR‑3613‑3p/MAP3K2/p38/caspase‑3 pathway regulates the heat‑stress‑induced apoptosis of endothelial cells.

Authors:  Jie Liu; Siya Xu; Shixin Liu; Bingguan Chen
Journal:  Mol Med Rep       Date:  2021-07-19       Impact factor: 2.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.